Results 171 to 180 of about 389 (236)

Soft Ionic and Electronic Triboelectric Nanogenerators: Toward Attachable and Implantable Biomedical Applications

Advanced Materials, Volume 38, Issue 32, 8 June 2026.
This review provides an overview of triboelectric nanogenerator (TENG)–based biomedical applications by classifying studies into electronic and ionic systems across attachable and implantable platforms. It summarizes key material choices, device structures, and working mechanisms that characterize current TENG‐based research, and outlines six future ...
Kyongtae Choi, Jimin Park, Won Jun Song, Soohwan An, Seonggyu Choe, Byeong‐Rak Keum, Min Young Kim, Dae Hee Hwang, Young‐Geun Park, Sung‐Won Kim, Sangyul Baik, Gwang‐Bum Im, Younghoon Lee   +12 more
wiley   +1 more source

FASLG Derived from Fibroblasts in Hydroxyapatite‐Rich Microenvironment Induces Urothelial Anoikis to Trigger Randall's Plaque Exposure

Advanced Science, Volume 13, Issue 34, 19 June 2026.
Randall's plaques (RP) serve as the nidus for calcium oxalate (CaOx) kidney stones. The current study reveals that hydroxyapatite (HAP) crystals activate the THY1–GSK3α/β–β‐catenin axis in renal interstitial fibroblasts (hRIFs), inducing FASLG secretion.
Minghui Liu, Maolan Wu, Meng Gao, Yongchao Li, Miao Yuan, Zhangcheng Liao, Zhi Liu, Yizhou Wang, Yu Cui, Jinbo Chen, Cheng He, Zhiyong Chen, Feng Zeng, Hequn Chen, Zewu Zhu   +14 more
wiley   +1 more source

[Malignant urologic neoplasms and HLA antigen (1)].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1983
I, Kondo, H, Fujii, K, Suzuki, A, Kohdaira, K, Saito   +4 more
openaire   +1 more source

Large‐Scale Quantitative Morphometry of Platelet α‐Granules via SIM Super‐Resolution Microscopy for Cancer Liquid Biopsy

Advanced Science, Volume 13, Issue 34, 19 June 2026.
ABSTRACT Blood‐based liquid biopsies hold transformative potential for non‐invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer‐associated responses, represent a compelling yet largely unexplored alternative.
Yan Ma, Huan Deng, Zelin Liu, Simei Zhong, Liangliang Wang, Mu He, Ning Jing, Lihua Dai, Yuzhen Basang, Xiao‐Yu Hu, Changyi Zhang, Huimin Zeng, Haoren Shao, Zhe Yang, Shanshan Zhao, Xiaohai Hu, Chuanjie Zhang, Xiaowei Wu, Jing Xu, Shaoqun Zeng, Jing Yuan, Qiang Li, Ziwei Qu, Zhenya Hong, Lingjuan Chen, Hanhua Dong, Jia Guo, Zhiqiang Han, Yu‐Hui Zhang   +28 more
wiley   +1 more source

1H MR‐based detection of human plasma metabolic alterations in clear cell renal cell carcinoma

BJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objectives This study aimed to evaluate the potential of plasma‐based proton magnetic resonance spectroscopy (1H‐MRS) for non‐invasive discrimination between clear cell renal cell carcinoma (ccRCC), benign renal masses (angiomyolipoma and oncocytoma) and healthy controls by identifying disease‐specific metabolic signatures.
Raj Kumar Sharma, Meiyappan Solaiyappan, Ardit Feinaj, Stephan Brönimann, Nirmish Singla, Zaver M. Bhujwalla, Yasser Ged   +6 more
wiley   +1 more source

The impact of high‐grade complications on quality of life and psychosocial distress in the early period after radical cystectomy

BJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objectives This study aims to investigate the impact of high‐grade complications (i.e., Clavien‐Dindo Classification [CDC] Grade ≥III) on quality of life (QoL) and psychosocial distress (PD) in the early period after radical cystectomy (RC) and urinary diversion. Patients and Methods The study relied on prospectively collected data of patients
Guido Müller, Henning Bahlburg, Mayumi Götte, Marius Cristian Butea‐Bocu, Florian Roghmann, Joachim Noldus   +5 more
wiley   +1 more source

Multicentre real‐world evaluation of the Haematuria Cancer Risk Score to risk‐stratify the detection of bladder cancer in patients referred from primary care

BJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objectives To investigate the potential of the Haematuria Cancer Risk Score (HCRS) to improve the real‐world investigation pathway for suspected bladder cancer. Materials and methods Data were retrospectively analysed for all consecutive patients referred with suspected urinary tract cancer on a faster diagnostic pathway to five UK ...
Tom Malik, Jonathan Denfhy, Hpone Theinkha Lin, Lubna Mohammed, Lin Aung Han, Kirthana Babureddy, Amber Pankhurst, Edward Tudor, Amina Buba, Laura Waley, Aashna Bali, Gemma Shaw, Edward Jefferies, Jessica Head, Tirion Smith, Jade Brown, Neil Trent, Sian Dudley, Sunil Mathur, Jonathan Aning   +19 more
wiley   +1 more source

DaRenCa risk score: A prognostic model for recurrence in clear cell renal cell carcinoma

BJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objective This study aimed to investigate whether a machine‐learning model improves the assessment of postsurgical recurrence‐free survival in patients with non‐metastatic clear cell renal cell carcinoma (ccRCC) compared with a Cox proportional hazards (CPH) approach. Patients and Methods Patients undergoing curative surgery for non‐metastatic
Philip Hedegaard, Rasmus D. Petersson, Hayder Al‐Husseinawi, Emma Heeno, Marina Lunetcas, Sara Tolouee, Rasmine Bak, Ole B. Pedersen, Juan L. Vásquez, Lars Lund, Frederik F. Thomsen   +10 more
wiley   +1 more source

‘BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 2026

BJU International, Volume 138, Issue 1, Page 14-21, July 2026.
Vignesh T. Packiam, Peter C. Black, James W. F. Catto, Saum Ghodoussipour, Max Kates, Ashish M. Kamat, Yair Lotan, Michael A. O’Donnell, Jeremy Y. C. Teoh, George N. Thalmann, Stephen B. Williams   +10 more
wiley   +1 more source

Validation of the Measure of Case‐Discussion Complexity and the Metric for the Observation of Decision‐Making for Streamlining Workflow and Evaluating Decision‐Making in US Tumor Boards

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Clinical guidelines for cancer care recognize multidisciplinary tumor boards (MTBs) as a gold standard for providing quality of care for cancer patients. However, the requirements and workflow for MTBs varies across countries, influencing their roles in decision making, care efficiency, and medical education.
T. Soukup, N. Lajmi, M. S. Prime, B. W. Lamb, W. Zhang, G. Markollari, R. Ortiz, S. Perrigo, K. Stuart, M. Wallace, K. Noyes, R. D. Hammer   +11 more
wiley   +1 more source